Quality of Life in Primary Hyperparathyroidism

Endocrinol Metab Clin North Am. 2022 Dec;51(4):837-852. doi: 10.1016/j.ecl.2022.04.007.

Abstract

Quality of life is impaired in primary hyperparathyroidism (PHPT), regardless of the severity of the disease. Clinical studies have employed different instruments, including standardized and disease-specific questionnaires, and including patients with different phenotypes of PHPT. Neuropsychiatric symptoms and decline in cognitive status are common in PHPT. Patients may complain of these issues or they can be ascertained by questionnaires; they include depression, anxiety, impaired vitality, social and emotional functions, sleep disturbances, and altered mental function. Randomized controlled trials on the effects of surgical versus non-surgical treatments have collectively shown improvement in quality of life after parathyroidectomy, but results have been heterogeneous.

Keywords: Cognition; Neurologic; Neuropsychiatric; Primary hyperparathyroidism; Quality of life.

Publication types

  • Review

MeSH terms

  • Humans
  • Hyperparathyroidism, Primary* / complications
  • Hyperparathyroidism, Primary* / therapy
  • Parathyroidectomy / methods
  • Parathyroidectomy / psychology
  • Prospective Studies
  • Quality of Life*
  • Surveys and Questionnaires